NEWS IN BRIEF

WuXi BioLogics wins Adagene antibody therapeutics contract

By Flora Southey contact

- Last updated on GMT

GettyImages/Toa55
GettyImages/Toa55
WuXi BioLogics will develop and manufacture Adagene’s antibody therapeutics for the Chinese market before expanding globally.

The strategic collaboration will see the Hong-Kong-headquartered contract development and manufacturing organisation (CDMO) make antigen-focused therapies.

“This collaboration is expected to introduce the world-class life-saving biologics to the Chinese market, and then benefit patients around the world,” ​said WuXi BioLogics CEO Chris Chen in a statement​.

The antibody therapeutics will be developed at WuXi BioLogics’ biologics development facility​ in Shanghai, and made at its manufacturing site​ in WuXi City, spokesperson Lia Jia told us.

WuXi BioLogics’ manufacturing plant – located 100km west of Shanghai – consists of two 1,000L single-use bioreactors, and 14 2,000L fed-batch cell culture disposable vessles supplied​ by vendor Thermo Fisher.

Three months ago the CDMO announced​ it had initiated current good manufacturing practice (cGMP) production at the site.

At the time, WuXi BioLogics told told Biopharma-Reporter the facility’s 30,000L capacity was already “mostly filled.”

Related news

Show more

Related products

show more

Removing Aggregates of an Acidic Monoclonal Antibody

Removing Aggregates of an Acidic Monoclonal Antibody

Bio-Rad Laboratories | 22-Oct-2018 | Technical / White Paper

CHT Ceramic Hydroxyapatite Media/Resins are known as the industry gold standard for
impurity removal during monoclonal antibody (mAb) purification....

Single-Step Influenza and Dengue Virus Purification

Single-Step Influenza and Dengue Virus Purification

Bio-Rad Laboratories | 08-Oct-2018 | Application Note

CHT XT is the newest addition to the CHT family of media. It has been designed for superior physical robustness to ensure it can be used repeatedly over...

Downstream Purification of Large Biomolecules

Downstream Purification of Large Biomolecules

Bio-Rad Laboratories | 17-Sep-2018 | Research Study

Our newest strong anion exchange resin provides both high binding capacity and
high recovery, even at high flow rates. A rigid bead complete with...

Related suppliers

Follow us

Products

View more

Webinars